Require pharmaceutical companies to include clear information about drug side effects in all television advertisements.
One policy goal, tracked across every bill that has carried it.
What’s happening with Responsibility in Drug Advertising Act of 2025?
The Responsibility in Drug Advertising Act of 2025, known as H.R. 1117, has been in the House Committee on Energy and Commerce since February 6, 2025. The committee members must act to move the bill forward, but the binding constraint is that most bills never receive a committee vote. Historical data shows that committee inaction is the most common way for legislation to end without reaching the floor.
Updated July 9, 2026 · Generated by AI. Always verify with official sources.
Where it stands
Now carried by Responsibility in Drug Advertising Act of 2025 (H.R. 1117 (119th)) →
Legislative Progress
No action since February 2025
Next up: A house committee · Nothing moves until they act.
How we got here
Every bill that has carried this goal, oldest first.
Died with Congress · Jan 3, 2025
Died when the 118th Congress ended without final passage. Bills must be reintroduced under a new number to be revived.
Reintroduced · Jan 3, 2025
Reintroduced from H.R. 9142 (118th), which died when its Congress ended.
H.R. 9142 (118th) →
Vehicles
Who’s behind it
Rosa DeLauro (D-CT)Wrote and sponsored the current bill.